Benefit of Roux-en-Y (R-Y) Reconstruction After Pancreaticoduodenectomy
Benefit of R-Y Reconstruction After Pancreaticoduodenectomy
1 other identifier
interventional
40
1 country
1
Brief Summary
One of the most common complications of pancreaticoduodenectomy (PD) is delayed gastric emptying (DGE), otherwise known as "gastroparesis," which is not fatal but results in prolonged hospital stay and increased hospital costs. Delayed gastric emptying is defined as nasogastric decompression after postoperative day (POD) 10 or a failure to tolerate a regular diet after POD 14. The incidence of DGE has been reported to range from 5% to 72%.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable pancreatic-cancer
Started Apr 2003
Longer than P75 for not_applicable pancreatic-cancer
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2003
CompletedFirst Submitted
Initial submission to the registry
May 19, 2009
CompletedFirst Posted
Study publicly available on registry
May 21, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2010
CompletedJuly 23, 2009
July 1, 2009
7 years
May 19, 2009
July 22, 2009
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
the incidence of DGE
3-6 months
Secondary Outcomes (1)
the incidence of other complication associated with reconstruction
3-6 months
Study Arms (2)
R-Y reconstruction
EXPERIMENTALthe reconstruction was performed by R-Y anastomosis
conventional reconstruction
NO INTERVENTIONthe anastomosis was performed by B-II
Interventions
The reconstruction was performed by R-Y anastomosis.
Eligibility Criteria
You may qualify if:
- These patients were to undergo elective pancreatic head resection for the treatment of periampullary mass
You may not qualify if:
- A body weight loss greater than 10% during the six months prior to surgery
- The presence of distant metastases
- Seriously impaired function of vital organs due to respiratory, renal or heart disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Kochi Universitylead
Study Sites (1)
Kochi Medical School
Nankoku, Kochi, 783-8505, Japan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Kazuhiro Hanazaki, Prof
Kochi University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
May 19, 2009
First Posted
May 21, 2009
Study Start
April 1, 2003
Primary Completion
April 1, 2010
Study Completion
April 1, 2010
Last Updated
July 23, 2009
Record last verified: 2009-07